By: IPP Bureau
Last updated : March 19, 2025 11:21 am
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Indegene, a digital-first life sciences commercialization company, has been recognized among Financial Times (FT) High-Growth Companies in Asia-Pacific 2025.
Recognized for the second year in a row, the ranking features companies across Asia-Pacific with the strongest revenue growth - particularly those that harness technology or adapt business models to keep expanding. This recognition is a testimony to Indegene’s growth, driven by deep expertise and contextualized technology.
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products. Its client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. Indegene has about 5,000 employees worldwide, six operation hubs and 18 offices across North America, Europe, and Asia.